Eagle Pharmaceuticals
EGRX
#9801
Rank
โ‚ฌ9.21 M
Marketcap
0,71ย โ‚ฌ
Share price
-11.76%
Change (1 day)
-91.99%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): โ‚ฌ32.75 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.25 Billion. In 2022 the company made an earning of โ‚ฌ62.45 Million, an increase over its 2021 earnings that were of -โ‚ฌ2.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚ฌ32.75 M-47.55%
2022 โ‚ฌ62.45 M-2361.45%
2021 -โ‚ฌ2.77 Million-111.53%
2020 โ‚ฌ23.94 M2.31%
2019 โ‚ฌ23.4 M-32.89%
2018 โ‚ฌ34.86 M-50.35%
2017 โ‚ฌ70.22 M38.63%
2016 โ‚ฌ50.65 M1966.43%
2015 โ‚ฌ2.45 M-111.46%
2014 -โ‚ฌ21.4 Million282.82%
2013 -โ‚ฌ5.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ17.43 B 51,485.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.95 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ12.06 B 35,604.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.78 B 2,219.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ4.43 B 13,021.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.62 B 28,365.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.53 Billion-19,393.87%๐Ÿ‡บ๐Ÿ‡ธ USA